A Phase 1 clinical trial testing TLX101-Tx, Telix Pharmaceuticals‘ experimental treatment for glioblastoma (an aggressive form of glioma),…
Articles by Marisa Wexler, MS
A large clinical trial testing Merck’s therapy candidate sacituzumab tirumotecan (sac-TMT) in people with hard-to-treat endometrial cancer has achieved…
A Phase 1 clinical trial testing the experimental therapy KLN-1010 in people with relapsed or refractory multiple myeloma has…
The U.S. Food and Drug Administration (FDA) has approved a new combination therapy — Inqovi (decitabine and cedazuridine) plus Venclexta…
The U.S. Food and Drug Administration (FDA) has given Actuate Therapeutics the green light to begin a clinical trial…
In an early clinical trial testing the novel therapy Alpha DaRT for recurrent glioblastoma, the first three patients given the…
Liraltagene autoleucel (lira-cel), an experimental cell therapy in clinical development for recurrent ovarian cancer, has been tolerated well so far…
Cellcentric has raised $220 million in financing to support two clinical trials testing its potentially first-in-class oral therapy inobrodib…
A new genetic test for a group of blood cancers known as myeloid malignancies is expected to soon be…
An artificial intelligence (AI) tool can detect early-stage pancreatic cancer on standard medical scans up to three years before…